Trial · NCT07910136
Pre-Examination Reflexology for Anxiety and Pain During Pelvic Examination
NCT07910136, Not applicable, Not yet recruiting, Goni Sintov
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pre-Examination Reflexology for Anxiety and Pain During Pelvic Examination. Trials, record NCT07910136. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07910136
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pre-Examination Reflexology for Anxiety and Pain During Pelvic Examination
- NCT number
- NCT07910136
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 120 participants, estimated
- Lead sponsor
- Goni Sintov
- Conditions
- Anxiety
- Interventions
- Pre-Examination Reflexology
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in maternal state anxiety measured by STAI-S | Approximately 15 minutes | Change in maternal state anxiety from baseline to immediately before the pelvic examination, measured using the State-Trait Anxiety Inventory-State (STAI-S) questionnaire. The State-Trait Anxiety Inventory - State (STAI-S) consists of 20 items, with total scores ranging from 20 to 80. Higher scores indicate greater state anxiety and therefore a worse outcome. Anxiety will be assessed at baseline and again after the 15-minute intervention or rest period. |
| Primary | Change in maternal state anxiety measured by VAS-Anxiety | Approximately 15 minutes | Change in maternal state anxiety from baseline to immediately before the pelvic examination, measured using the Visual Analog Scale for Anxiety (VAS-Anxiety). The Visual Analog Scale for Anxiety (VAS-Anxiety) ranges from 1 to 10, with higher scores indicating greater anxiety and therefore a worse outcome. Anxiety will be assessed at baseline and again after the 15-minute intervention or rest period. |
| Secondary | Pain intensity during the pelvic examination | Immediately after the pelvic examination | Pain intensity during the pelvic examination, measured immediately after the examination using the Visual Analog Scale (VAS), with scores ranging from 1 to 10. Higher scores indicate greater pain intensity and therefore a worse outcome. |
| Secondary | Patient satisfaction with the pelvic examination | Immediately after the pelvic examination | Patient satisfaction with the pelvic examination, assessed using a patient satisfaction questionnaire immediately after the examination. |
| Secondary | Change in blood pressure | Approximately 15 minutes | Change in blood pressure from baseline to after the 15-minute intervention or rest period and before the pelvic examination. Systolic and diastolic blood pressure will be assessed at both time points. |
| Secondary | Change in heart rate | Approximately 15 minutes | Change in heart rate from baseline to after the 15-minute intervention or rest period and before the pelvic examination. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers10
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07910136
GET https://conductscience.org/api/trials/v1/NCT07910136/registered